SCHEDULE: Vanguard Group Boosts Henry Schein Stake to 9.89%

The Vanguard Group has reported an increased beneficial ownership of 9.89% in Henry Schein Inc., holding over 12 million shares of common stock.

Summary

• The Vanguard Group reported beneficial ownership of 12,000,776 shares of Henry Schein Inc. common stock.
• This represents 9.89% of the class of securities.
• The filing date is October 30, 2025, with the event date being September 30, 2025.
• Vanguard holds sole dispositive power over 11,117,514 shares and shared dispositive power over 883,262 shares.
• Shared voting power is held over 576,457 shares, with no sole voting power.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership by a large institutional investor, providing factual information without indicating positive or negative operational performance or strategic shifts for the issuer.

Positives

• A major institutional investor, The Vanguard Group, holds a significant 9.89% stake in Henry Schein Inc., indicating institutional confidence.
• The holding is for investment purposes in the ordinary course of business, not for control, suggesting stability in the shareholder base.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Industry Context

The investment by The Vanguard Group, a prominent investment adviser, in Henry Schein Inc. reflects typical institutional portfolio allocation within the healthcare distribution sector. Henry Schein is a leading provider of dental, animal health, and medical products and services, making it a significant player in its industry.

Comparison to Industry Standards

• Institutional ownership by major investment advisers like The Vanguard Group is a common characteristic for large-cap companies like Henry Schein Inc., aligning with standard portfolio diversification and passive/active investment strategies across the market.

Stakeholder Impact

• Shareholders: Increased institutional ownership may provide a perception of stability and confidence in the company.

Key Dates

Recommendation

This Schedule 13G filing primarily discloses a passive institutional ownership stake by The Vanguard Group in Henry Schein Inc. While a significant holding by a major investor can be seen as a vote of confidence, the filing itself does not contain operational or financial performance data, strategic updates, or any other information that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals and market conditions rather than this specific ownership disclosure.

Keywords

Henry Schein, Vanguard Group, Common Stock, Schedule 13G, Institutional Ownership, Investment Adviser, Healthcare Distribution